Expertise in
11
conditions

Andrejs Erglis

Pilsonu Street 13, 
Riga, RIX, LV 
Expertise in
11
conditions
Pilsonu Street 13, 
Riga, RIX, LV 

Overview

Andrejs Erglis practices practicing medicine in Riga, Latvia.

Mr. Erglis is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Heart Attack, Stable Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.

He is actively involved in clinical research, co-authoring 207 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

Pilsonu Street 13, Riga, RIX 1002, Latvia
Other Locations
3 Jelgavas Street, Riga, RIX LV1004, Latvia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial
Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients With Hypertension: A Double-Blind Randomized Trial
Enrollment Status: Terminated
Publish Date: June 18, 2026
Intervention Type: Device
Study Phase: Not Applicable
Cerebral Protection in Transcatheter Aortic Valve Replacement - The PROTEMBO C Trial
Cerebral Protection in Transcatheter Aortic Valve Replacement - The PROTEMBO C Trial
Enrollment Status: Completed
Publish Date: May 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
Enrollment Status: Completed
Publish Date: June 07, 2024
Intervention Type: Device
Study Phase: Phase 4
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
Enrollment Status: Unknown
Publish Date: February 10, 2023
Intervention Type: Device
Influenza Vaccination After Myocardial Infarction (IAMI Trial): A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on National Angiography and Angioplasty Registries
Influenza Vaccination After Myocardial Infarction (IAMI Trial): A Multicenter, Prospective, Randomized Controlled Clinical Trial Based on National Angiography and Angioplasty Registries
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Biological
Study Drug: Influenza vaccine
Study Phase: Phase 4
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Enrollment Status: Completed
Publish Date: May 14, 2021
Intervention Type: Device
Study Phase: Phase 3
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
Enrollment Status: Completed
Publish Date: December 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
BIO|MASTER.Ilivia Family / Plexa
BIO|MASTER.Ilivia Family / Plexa
Enrollment Status: Completed
Publish Date: May 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

207 Total Publications

Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
Journal: Circulation
Published: August 31, 2026

Frequently Asked Questions about Andrejs Erglis

Is Andrejs Erglis a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Andrejs Erglis is classified as an Elite expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrejs Erglis participate in research or clinical trials?

Yes. Andrejs Erglis has published 207 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Andrejs Erglis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Erglis's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile